Fujifilm Corporation has launched the Bio CDMO Division to expand its contract development and manufacturing operations for biopharmaceuticals, in response to strong market growth expectations. The ratio of biopharmaceuticals in the pharmaceutical market is rising, and is expected to continue expanding. As biopharmaceuticals manufacturing requires the advanced technologies and facilities for culturing, separation and purification of proteins, there is growing demand that pharmaceutical compan...